BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16483922)

  • 1. B lymphocytes on the front line of autoimmunity.
    Youinou P; Hillion S; Jamin C; Pers JO; Saraux A; Renaudineau Y
    Autoimmun Rev; 2006 Mar; 5(3):215-21. PubMed ID: 16483922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctional B cells in systemic lupus erythematosus.
    Renaudineau Y; Pers JO; Bendaoud B; Jamin C; Youinou P
    Autoimmun Rev; 2004 Nov; 3(7-8):516-23. PubMed ID: 15546800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocytes are required for development and treatment of autoimmune diseases.
    Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y
    Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell conducts the lymphocyte orchestra.
    Youinou P
    J Autoimmun; 2007; 28(2-3):143-51. PubMed ID: 17363215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases.
    Youinou P; Renaudineau Y
    Thromb Res; 2004; 114(5-6):363-9. PubMed ID: 15507266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in the understanding of B-cell functions in autoimmunity.
    Porakishvili N; Mageed R; Jamin C; Pers JO; Kulikova N; Renaudineau Y; Lydyard PM; Youinou P
    Scand J Immunol; 2001; 54(1-2):30-8. PubMed ID: 11439145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.
    Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F
    Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paradox of CD5-expressing B cells in systemic lupus erythematosus.
    Youinou P; Renaudineau Y
    Autoimmun Rev; 2007 Dec; 7(2):149-54. PubMed ID: 18035326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD5: a safeguard against autoimmunity and a shield for cancer cells.
    Dalloul A
    Autoimmun Rev; 2009 Feb; 8(4):349-53. PubMed ID: 19041428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple paths to loss of anergy and gain of autoimmunity.
    Conrad FJ; Rice JS; Cambier JC
    Autoimmunity; 2007 Sep; 40(6):418-24. PubMed ID: 17729035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central tolerance: essential for preventing autoimmune disease?
    von Boehmer H
    Eur J Immunol; 2009 Sep; 39(9):2313-6. PubMed ID: 19714571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
    Youinou P; Pers JO; Jamin C; Lydyard PM
    Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic science for the clinician 54: CD5.
    Sigal LH
    J Clin Rheumatol; 2012 Mar; 18(2):83-8. PubMed ID: 22334268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
    Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell self-tolerance in humans.
    Wardemann H; Nussenzweig MC
    Adv Immunol; 2007; 95():83-110. PubMed ID: 17869611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell tolerance and autoimmunity.
    Tsubata T; Honjo T
    Rev Immunogenet; 2000; 2(1):18-25. PubMed ID: 11324689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of self-reactive B cells and autoimmune diseases.
    Burrows PD; Suematsu S; Watanabe T
    Rev Immunogenet; 2000; 2(1):38-51. PubMed ID: 11324692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of B lymphocytes in the progression from autoimmunity to autoimmune disease.
    Salinas GF; Braza F; Brouard S; Tak PP; Baeten D
    Clin Immunol; 2013 Jan; 146(1):34-45. PubMed ID: 23202542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell: a logical target for treatment of rheumatoid arthritis.
    Youinou P; Jamin C; Saraux A
    Clin Exp Rheumatol; 2007; 25(2):318-28. PubMed ID: 17543163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells.
    Mabrouk I; Buart S; Hasmim M; Michiels C; Connault E; Opolon P; Chiocchia G; Lévi-Strauss M; Chouaib S; Karray S
    Immunity; 2008 Dec; 29(6):922-33. PubMed ID: 19013083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.